Business Description
PhotoCure ASA
ISIN : NO0010000045
Total Employee Number:
101Compare
Compare
Traded in other countries / regions
PHO.Norway0IMT.UKPHOO.SwedenPHCUF.USAPHS.Germany IPO Date
2018-09-28Description
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 18.62 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.06 | |||||
Interest Coverage | 2.77 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 6.75 | |||||
Beneish M-Score | -0.98 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.3 | |||||
3-Year EPS without NRI Growth Rate | 71.7 | |||||
3-Year Book Growth Rate | 2.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.18 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 40.74 | |||||
9-Day RSI | 42.29 | |||||
14-Day RSI | 42.57 | |||||
3-1 Month Momentum % | 8.59 | |||||
6-1 Month Momentum % | 5.38 | |||||
12-1 Month Momentum % | 37.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.79 | |||||
Quick Ratio | 4.38 | |||||
Cash Ratio | 2.01 | |||||
Days Inventory | 328.04 | |||||
Days Sales Outstanding | 53.22 | |||||
Days Payable | 193.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | 1.01 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 93.57 | |||||
Operating Margin % | 18.68 | |||||
Net Margin % | 12.55 | |||||
EBITDA Margin % | 26.36 | |||||
FCF Margin % | -0.49 | |||||
OCF Margin % | 3.32 | |||||
ROE % | 16.86 | |||||
ROA % | 11.76 | |||||
ROIC % | 22.6 | |||||
3-Year ROIIC % | 9520.52 | |||||
ROC (Joel Greenblatt) % | 234.81 | |||||
ROCE % | 23.71 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 18.87 | |||||
Forward PE Ratio | 33.91 | |||||
PE Ratio without NRI | 18.87 | |||||
PS Ratio | 2.37 | |||||
PB Ratio | 2.73 | |||||
Price-to-Tangible-Book | 4.93 | |||||
Price-to-Operating-Cash-Flow | 69.28 | |||||
EV-to-EBIT | 9.25 | |||||
EV-to-EBITDA | 7.7 | |||||
EV-to-Forward-EBITDA | 91.8 | |||||
EV-to-Revenue | 2.03 | |||||
EV-to-Forward-Revenue | 13.28 | |||||
EV-to-FCF | -450.02 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Projected-FCF | 2.1 | |||||
Price-to-Median-PS-Value | 0.45 | |||||
Price-to-Graham-Number | 2.04 | |||||
| Price-to-Net-Current-Asset-Value | 6.3 | |||||
Earnings Yield (Greenblatt) % | 10.81 | |||||
FCF Yield % | -0.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PhotoCure ASA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 58.507 | ||
| EPS (TTM) (€) | 0.283 | ||
| Beta | 0.0627 | ||
| 3-Year Sharpe Ratio | 0.4 | ||
| 3-Year Sortino Ratio | 0.81 | ||
| Volatility % | 41.97 | ||
| 14-Day RSI | 42.57 | ||
| 14-Day ATR (€) | 0.118951 | ||
| 20-Day SMA (€) | 5.3515 | ||
| 12-1 Month Momentum % | 37.95 | ||
| 52-Week Range (€) | 4.285 - 6.71 | ||
| Shares Outstanding (Mil) | 26.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PhotoCure ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PhotoCure ASA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-28 | In 124 days | ||
| Third quarter earnings results for 2026 | 2026-10-28 | In 124 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-29 | In 33 days | ||
| Second quarter earnings results for 2026 | 2026-07-29 | In 33 days | ||
| General meeting for 2025 | 2026-06-26 17:00 | In 1 day | ||
| First quarter earnings conference call for 2026 | 2026-05-07 14:00 | 6.06 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 6.06 (+0.00%) | ||
| Annual report for 2025 | 2026-04-27 | 6.26 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-18 14:00 | 5.34 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-18 07:00 | 5.34 (+0.00%) |
Show
Entries
PhotoCure ASA Frequently Asked Questions
What is PhotoCure ASA(FRA:PHS)'s stock price today?
The current price of FRA:PHS is €5.23. The 52 week high of FRA:PHS is €6.71 and 52 week low is €4.29.
When is next earnings date of PhotoCure ASA(FRA:PHS)?
The next earnings date of PhotoCure ASA(FRA:PHS) is 2026-07-29.
Does PhotoCure ASA(FRA:PHS) pay dividends? If so, how much?
PhotoCure ASA(FRA:PHS) does not pay dividend.
Press Release
Articles on PhotoCure ASA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers